Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community

作者: C. J. Ostgren , J. Merlo , L. Rastam , U. Lindblad ,

DOI: 10.1111/J.1462-8902.2004.00358.X

关键词:

摘要: Aim: To explore the prevalence of atrial fibrillation in patients with hypertension and type 2 diabetes to identify possible mechanisms for development fibrillation. Methods: A community-based, cross-sectional observational study was conducted primary health care Skara, Sweden, 1739 subjects (798 men, 941 women) were surveyed. Patients categorized as those only (n ¼ 597); both 171), 147). In reference population, 824 normotensive without identified used controls. Participants examined cardiovascular risk factors including fasting blood glucose, serum insulin, pressure, lipids anthropometric measures. Resting electrocardiogram (ECG) recorded Minnesota-coded. Insulin resistance measured by homeostasis model assessment (HOMA). Results: Age-adjusted 2% only, 6% diabetes, 4% controls, respectively. Age sex adjusted odds ratios (OR) (95% CI) were; 0.7 (0.30–1.5), combined 3.3 (1.6–6.7), 2.0 (0.9–4.7). The association remained significant when disease (CVD) body mass index (BMI), attenuated adjustment ischemic ECG; 2.4 (1.1–5.0) lost significance insulin resistance; 1.3 (0.5–3.1). Conclusions: Atrial is associated occurrence hypertension. may be a common underlying mechanism.

参考文章(33)
LENNART RÅSTAM, GÖRAN BERGLUND, SVEN-OLOF ISACSSON, LARS RYDÉN, The Skaraborg hypertension project. III. Influence on blood pressure of a medical care program for hypertension. Acta Medica Scandinavica. ,vol. 219, pp. 261- 269 ,(2009) , 10.1111/J.0954-6820.1986.TB03309.X
E Bøg-Hansen, U Lindblad, J Ranstam, A Melander, L Råstam, Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project. Diabetes, Obesity and Metabolism. ,vol. 3, pp. 25- 31 ,(2001) , 10.1046/J.1463-1326.2001.00097.X
Emelia J Benjamin, Daniel Levy, Sonya M Vaziri, Ralph B D'Agostino, Albert J Belanger, Philip A Wolf, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. ,vol. 271, pp. 840- 844 ,(1994) , 10.1001/JAMA.1994.03510350050036
Martin K. Rutter, Helen Parise, Emelia J. Benjamin, Daniel Levy, Martin G. Larson, James B. Meigs, Richard W. Nesto, Peter W.F. Wilson, Ramachandran S. Vasan, Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function. Sex-Related Differences in the Framingham Heart Study Circulation. ,vol. 107, pp. 448- 454 ,(2003) , 10.1161/01.CIR.0000045671.62860.98
D.D. Reid, Peter Mccartney, P.J.S. Hamilton, Geoffrey Rose, R.J. Jarrett, Harry Keen, SMOKING AND OTHER RISK FACTORS FOR CORONARY HEART-DISEASE IN BRITISH CIVIL SERVANTS The Lancet. ,vol. 308, pp. 979- 984 ,(1976) , 10.1016/S0140-6736(76)90830-8
Wang Tj, Massaro Jm, D Levy, Vasan Rs, Wolf Pa, Agostino RB D, None, A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community JAMA. ,vol. 290, pp. 1049- 1056 ,(2003) , 10.1001/JAMA.290.8.1049
Wilbert S. Aronow, Chul Ahn, Hal Gutstein, Prevalence of Atrial Fibrillation and Association of Atrial Fibrillation with Prior and New Thromboembolic Stroke in Older Patients Journal of the American Geriatrics Society. ,vol. 44, pp. 521- 523 ,(1996) , 10.1111/J.1532-5415.1996.TB01436.X
Michael H. Criqui, Elizabeth Barrett-Connor, Mark J. Holdbrook, Melissa Austin, John D. Turner, Clustering of cardiovascular disease risk factors Preventive Medicine. ,vol. 9, pp. 525- 533 ,(1980) , 10.1016/0091-7435(80)90047-X
S. M. Haffner, H. Miettinen, M. P. Stern, The homeostasis model in the San Antonio Heart Study. Diabetes Care. ,vol. 20, pp. 1087- 1092 ,(1997) , 10.2337/DIACARE.20.7.1087